245 Users Online
Drug Eluting Beads Market Segmented By disease type such as Primary Liver Cancer (HCC) and Secondary Hepatic Malignancies (liver metastases) with product type such as Oncozene beads, Quadra Sphere, LC Beads
Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver.
Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor. Giving chemotherapy with the bead is more beneficial, as the chemotherapy is gradually released from the beads. Slowly released chemotherapy from the bead destroys the tumor over a greater period of time. Drug eluting beads are new embolic agents that allows the continuous release of chemotherapeutic agents.
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
The global drug eluting beads market is primarily driven by the increasing prevalence of liver diseases. Increasing awareness among people regarding the benefits of drug eluting beads therapy is also expected to drive the growth of the global drug eluting beads market. However, lack of skilled physicians is expected to restrain the market growth.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version| basis of disease type |
|
| basis of product type |
|
| basis of drug type |
|
| basis of end user |
|
The global drug eluting beads market is expected to show a significant growth over the forecast period. The number of population with the liver diseases has grown significantly and increasing demand for invasive treatment is expected to drive the growth of drug eluting beads market. In addition, the increasing adoption of this new technology by the patient is also driving the growth of drug eluting beads market.
Sales Team
Client Partner
The global drug eluting beads market can be segmented into regions: North America, Latin America, Europe, Asia Pacific and Middle East & Africa. North America region dominates the global drug eluting beads market. High adoption of new technologies in the region is expected to be the factor for the growth of drug eluting beads market.
Europe is expected to be the second biggest market for the global drug eluting beads market. Asia Pacific is expected to be the moderate growing region in the drug eluting beads market. Moreover, Latin America and Middle East and Africa are also expected to show moderate growth for drug eluting beads market during the forecast period.
The major key players of the global drug eluting beads market are Biocompatibles UK Ltd, BTG International Ltd., Merit Medical Systems, Inc, CeloNova BioSciences, Inc, ABK Biomedical, Inc., Boston Scientific Corporation, Medtronic, Inc., Merit Medical Systems, Inc., Surefire Medical, Inc., Terumo Corporation and others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
